This fusion leads to the constitutive activation of FGFR1; BCR-FGFR1 activates the ERK/MAPK and JAK/STAT pathways and exhibits transformative activity in NIH3T3 cells, promoting tumor development [39]. This evidence concerns the gene FGFR1 and neoplasm.